Name | devazepide |
---|---|
Synonyms |
N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide
Devazepida DEVAZEPIDE Devazepidum MK-329 |
Description | Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide (L-364,718) is effective for gastrointestinal disorders[1]. |
---|---|
Related Catalog | |
Target |
IC50: 45 pM (Rat pancreatic CCK receptor), 81 pM (Bovine gallbladder CCK receptor), 245 nM (Guinea pig brain CCK receptor)[1] |
References |
Density | 1.31g/cm3 |
---|---|
Boiling Point | 758.6ºC at 760mmHg |
Molecular Formula | C25H20N4O2 |
Molecular Weight | 408.45200 |
Flash Point | 412.6ºC |
Exact Mass | 408.15900 |
PSA | 77.56000 |
LogP | 3.62930 |
Vapour Pressure | 6.56E-23mmHg at 25°C |
Index of Refraction | 1.696 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
![]() GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300 |
Precautionary Statements | P264-P301 + P310 |
Hazard Codes | T |
Safety Phrases | 28-36/37-45 |
RIDADR | UN 2811 6.1 / PGI |
RTECS | NL5994460 |